US 'Bent' on Imposing China Tariffs Regardless of Fentanyl Progress, Beijing Says
The Trump administration is determined to impose tariffs on China “regardless” of any progress it makes on stopping fentanyl from flowing into the U.S., a Chinese Foreign Affairs Ministry spokesperson said Feb. 5 during a regular press conference in Beijing. The U.S. is “bent on levying a 10 percent additional tariff on Chinese imports under the pretext of the fentanyl issue,” the person said, adding that Beijing “firmly deplores and opposes this move and has taken necessary measures to defend its legitimate rights and interests.”
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
The spokesperson added that “tariff wars have no winners” and warned that “pressuring or threatening China is not a right way to engage with us. Reducing domestic demands for drugs and enhancing law enforcement cooperation is the fundamental solution to the fentanyl crisis in the U.S. China will firmly defend its legitimate rights and interests.” The Chinese Embassy in the U.S. provided the English translation of the press conference transcript.
China earlier this week retaliated against Trump’s tariffs with tariff measures of its own along with new export controls and trade restrictions against two U.S. companies (see 2502040011).